Watch: Ocasio-Cortez back CEO into a corner over why he charges Americans $2000 for drug that costs $8 in Australia

Watch: Ocasio-Cortez back CEO into a corner over why he charges Americans $2000 for drug that costs $8 in Australia
Images via Screengrab.

Rep. Alexandria Ocasio-Cortez (D-NY) on Thursday cornered the CEO of biotech firm Gilead Sciences about why his company charges nearly $2,000 for a drug that consumers in Australia can buy for just $8.

During a hearing of the House Oversight and Reform Committee, Ocasio-Cortez asked Gilead CEO Daniel O’Day about his company’s decision to charge over than 200 times more for HIV prevention pill Truvada than that people in other countries pay for the same drug.

“Truvada still has patent protection in the United States and in the rest of the world it is generic,” he said, and then claimed that it will be available as a generic drug in the U.S. in September 2020.

Ocasio-Cortez was not satisfied with this answer, however, and she pointed out that the drug was originally discovered to be effective in preventing HIV infections by a federal lab in Atlanta — and she said that the U.S. government had patented the drug’s use for such treatments.

“We the people developed this drug,” she said. “We paid for this drug… There is no reason this should be $2,000 a month. People are dying because of it!”

O’Day, however, has maintained that the patents the government has related to Truvada and HIV prevention are invalid.

Watch the video below.

Understand the importance of honest news ?

So do we.

The past year has been the most arduous of our lives. The Covid-19 pandemic continues to be catastrophic not only to our health - mental and physical - but also to the stability of millions of people. For all of us independent news organizations, it’s no exception.

We’ve covered everything thrown at us this past year and will continue to do so with your support. We’ve always understood the importance of calling out corruption, regardless of political affiliation.

We need your support in this difficult time. Every reader contribution, no matter the amount, makes a difference in allowing our newsroom to bring you the stories that matter, at a time when being informed is more important than ever. Invest with us.

Make a one-time contribution to Alternet All Access, or click here to become a subscriber. Thank you.

Click to donate by check.

DonateDonate by credit card
Donate by Paypal
{{ }}
@2023 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by